Get the Stockscreener App
505.22
1.28%
-6.56
After Hours:
505.22
Idexx Laboratories Inc stock is traded at $505.22, with a volume of 379.41K.
It is down -1.28% in the last 24 hours and up +4.96% over the past month.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 35% of its revenue from outside the United States.
See More
Previous Close:
$511.78
Open:
$510.74
24h Volume:
379.41K
Relative Volume:
0.84
Market Cap:
$41.24B
Revenue:
$3.78B
Net Income/Loss:
$845.63M
P/E Ratio:
51.55
EPS:
9.8
Net Cash Flow:
$838.95M
1W Performance:
-0.48%
1M Performance:
+4.96%
6M Performance:
-6.43%
1Y Performance:
+15.54%
1-Day Range:
$500.16
$512.62
1-Week Range:
$496.45
$518.97
52-Week Range:
$372.50
$583.39
Idexx Laboratories Inc Stock (IDXX) Company Profile
Name
Idexx Laboratories Inc
Sector
Industry
Phone
(207) 556-0300
Address
ONE IDEXX DRIVE, WESTBROOK, ME
Idexx Laboratories Inc Stock (IDXX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-30-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-07-23 | Initiated | Exane BNP Paribas | Outperform |
| Dec-04-23 | Upgrade | Cleveland Research | Neutral → Buy |
| Aug-02-23 | Downgrade | Atlantic Equities | Overweight → Neutral |
| Jul-25-22 | Downgrade | Stifel | Buy → Hold |
| Jul-21-22 | Upgrade | Goldman | Neutral → Buy |
| Jul-12-22 | Initiated | Piper Sandler | Overweight |
| May-05-22 | Downgrade | BofA Securities | Buy → Neutral |
| Feb-08-22 | Initiated | Atlantic Equities | Overweight |
| Nov-18-21 | Initiated | Morgan Stanley | Overweight |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-12-21 | Downgrade | Guggenheim | Buy → Neutral |
| Feb-17-21 | Initiated | Barclays | Overweight |
| Sep-09-19 | Initiated | Goldman | Neutral |
| May-23-19 | Initiated | Guggenheim | Buy |
| Nov-02-18 | Reiterated | BofA/Merrill | Buy |
| May-07-18 | Reiterated | Stifel | Buy |
| Jan-16-18 | Initiated | Piper Jaffray | Overweight |
| Aug-23-17 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jul-28-17 | Upgrade | CL King | Neutral → Buy |
| Feb-03-17 | Downgrade | Feltl & Co. | Hold → Sell |
| Sep-29-16 | Resumed | BofA/Merrill | Neutral |
| Aug-16-16 | Reiterated | Stifel | Buy |
| Aug-03-16 | Upgrade | Northcoast | Sell → Neutral |
| Jul-20-16 | Reiterated | Canaccord Genuity | Buy |
| Apr-19-16 | Reiterated | Canaccord Genuity | Buy |
| Apr-01-16 | Initiated | CL King | Neutral |
| Mar-21-16 | Reiterated | Stifel | Buy |
| Feb-04-16 | Initiated | Credit Suisse | Outperform |
| Oct-29-15 | Reiterated | Stifel | Buy |
| Aug-28-15 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Aug-13-15 | Reiterated | Stifel | Buy |
| Jul-23-15 | Reiterated | Canaccord Genuity | Buy |
View All
Idexx Laboratories Inc Stock (IDXX) Latest News
IDEXX Laboratories to Release 2024 Third Quarter Financial Results - StockTitan
IDEXX Laboratories (NASDAQ:IDXX) Ticks All The Boxes When It Comes To Earnings Growth - Yahoo Finance
The Manufacturers Life Insurance Company Raises Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
IDEXX Laboratories' SWOT analysis: vet diagnostics leader faces visit decline - Investing.com
Scientech Research LLC Invests $580,000 in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
IDEXX Laboratories Inc. stock outperforms competitors on strong trading day - MarketWatch
Deerfield Management Company L.P. Series C Makes New $933,000 Investment in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Shares Sold by Bank of Montreal Can - MarketBeat
Intech Investment Management LLC Has $1.40 Million Stock Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Magnetar Financial LLC Sells 1,417 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
IDEXX Laboratories Inc. stock rises Monday, still underperforms market - MarketWatch
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Shares Bought by J. Stern & Co. LLP - MarketBeat
Epoch Investment Partners Inc. Has $90.16 Million Stock Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
IDEXX Laboratories Inc. stock underperforms Friday when compared to competitors - MarketWatch
Quest Partners LLC Decreases Stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
IDEXX Laboratories Inc. stock rises Thursday, still underperforms market - MarketWatch
Thoroughbred Financial Services LLC Invests $201,000 in IDEX Co. (NYSE:IEX) - Defense World
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Holdings Reduced by Inspire Investing LLC - MarketBeat
DCX Systems bags Rs 155-cr order from Israeli defence co; stock rises 5% - Business Standard
DCX Systems shares rise 5% on Rs 154-cr order win from Israel - Moneycontrol
As Top Dog in Pet Diagnostics, Idexx Has Dug a Wide Moat - Morningstar
IDEX Corporation Declares Regular Quarterly Cash Dividend - Business Wire
Disclosure of Voting Rights in IDEX Biometrics to Chair, Morten Opstad18 Sep 2024 - GlobeNewswire
IDEX Biometrics Schedules EGM for Share Issuance Decisions - TipRanks
Blair William & Co. IL Trims Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Notice of IDEX Biometrics extraordinary general meeting on 9 October 2024 - GlobeNewswire
We Think IDEXX Laboratories (NASDAQ:IDXX) Can Manage Its Debt With Ease - Simply Wall St
Ideaya Biosciences announces Douglas Snyder as general counsel - TipRanks
IDEX Biometrics Enters Amended Bond Agreement - TipRanks
IDEX Biometrics ASAAmended terms of convertible bond agreement, Commitment letter signed - The Tech Outlook
IDEX Biometrics ASAAmended terms of convertible bond agreement, Commitment letter signed - GlobeNewswire
Sofinnova Investments Inc. Has $31.11 Million Stock Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Idex Biometrics: quarterlies, annuals, regulatory actions - Biometric Update
StockNews.com Upgrades Digimarc (NASDAQ:DMRC) to Sell - MarketBeat
IDEX Biometrics Raises NOK 70 Million in Oversubscribed Placement - TipRanks
IDEXKey information relating to possible subsequent offering (repair offering) Sep 2024 - GlobeNewswire
IDEX Biometrics ASA: Private placement of NOK 70 million successfully placed - GlobeNewswire
IDEX Biometrics Announces Share Placement and Warrants Issuance - TipRanks
IDEX Biometrics ASAContemplated Private Placement and Amended Terms of Convertible Bond Agreement - GlobeNewswire
Oppenheimer Asset Management Inc. Buys 1,453 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Arizona State Retirement System Increases Holdings in IDEAYA Biosciences, Inc. (NASDAQ:IDYA) - Defense World
IDEXX Laboratories (MEX:IDXX) Debt-to-EBITDA : 0.89 (As of Jun. 2024) - GuruFocus.com
Forsta AP Fonden Buys 4,900 Shares of IDEX Co. (NYSE:IEX) - Defense World
Rathbones Group PLC Acquires 16,975 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Victory Capital Management Inc. Boosts Stock Position in IDEX Co. (NYSE:IEX) - Defense World
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Receives $582.25 Average Price Target from Analysts - MarketBeat
State of New Jersey Common Pension Fund D Sells 16,602 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
iDEX, Defence Innovation Unit ink MoU to increase cooperation in defence innovation - The Hindu
Achmea Investment Management B.V. Has $11.31 Million Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
iDEX & Defence Innovation Unit ink MoU to increase co-operation in defence innovation - Devdiscourse
California hosts third edition of INDUS-X Summit, DIU,iDEX sign MoU to increase innovation in defence sector - indiablooms
Idexx Laboratories Inc Stock (IDXX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.28%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):